Directory
>
Carl Kraus Dfacp
Carl Kraus Dfacp
Chief Medical Officer | Aquestive Therapeutics
Raleigh, North Carolina, United States
Carl Kraus Dfacp
Summary
Carl Kraus is a seasoned Chief Medical Officer with extensive experience in the biotechnology and pharmaceutical industries. He currently leads medical affairs at Aquestive, where he focuses on innovative drug development and regulatory strategies. With a solid foundation in medicine, having earned his M.D. from Washington University in St. Louis, Carl has a strong background in clinical research, particularly in infectious diseases and oncology. His career spans various leadership roles, including founding a company and serving as a Vice President in scientific affairs. Carl is adept at navigating the complexities of drug development and regulatory submissions, making him a valuable asset in the healthcare sector. Furthermore, his experience at the FDA provides him with unique insights into regulatory processes. Outside of his professional life, Carl is passionate about mentorship and fostering the next generation of healthcare leaders.
Carl Kraus Dfacp
Work Experience
Chief Medical Officer at
Aquestive Therapeutics
June 2023 - Present
Chief Medical Officer at
Aceragen
November 2021 - April 2023
Founder and Chief Executive Officer at
Arrevus
January 2017 - October 2021
Chief Medical Officer at
Resilience Government Services, Inc.
February 2013 - January 2017
Vice President, Medical Affairs, Risk Management/REMS at
Medscape
May 2010 - January 2013
Vice President, Scientific Affairs at
Icon
June 2008 - May 2010
Vice President, Scientific Affairs/Clinical Informatics at
UnitedHealth Group
May 2005 - May 2008
Medical Officer at
Center For Drug Evaluation And Research Us Food And Drug Administration
March 2002 - April 2005
Clinical Associate at
National Institute Of Allergy And Inf Diseases Nih
January 1999 - January 2003
Medical Resident at
UChicago Medicine
January 1995 - January 1999
Carl Kraus Dfacp
Education
Washington University in St. Louis School of Medicine, M.D.
January 1991 - January 1995
Washington University in St. Louis, B.A.
January 1987 - January 1991
Frequently Asked Questions about Carl Kraus Dfacp
What is Carl Kraus Dfacp email address?
Carl Kraus Dfacp's primary email address is ******@aquestive.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Carl Kraus Dfacp work for?
Carl Kraus Dfacp is a Chief Medical Officer at Aquestive Therapeutics, a company specializing in Biological products, except diagnostic.
Where Carl Kraus Dfacp graduated from?
Carl Kraus Dfacp holds a degree in Medicine from Washington University in St. Louis School of Medicine.
How can I directly contact Carl Kraus Dfacp?
To contact Carl Kraus Dfacp directly, you can use the email address ******@aquestive.com. Complete contact information is available upon registration with Muraena.
Who is Carl Kraus Dfacp?
Carl Kraus is a seasoned Chief Medical Officer with extensive experience in the biotechnology and pharmaceutical industries. He currently leads medical affairs at Aquestive, where he focuses on innovative drug development and regulatory strategies. With a solid foundation in medicine, having earned his M.D. from Washington University in St. Louis, Carl has a strong background in clinical research, particularly in infectious diseases and oncology. His career spans various leadership roles, including founding a company and serving as a Vice President in scientific affairs. Carl is adept at navigating the complexities of drug development and regulatory submissions, making him a valuable asset in the healthcare sector. Furthermore, his experience at the FDA provides him with unique insights into regulatory processes. Outside of his professional life, Carl is passionate about mentorship and fostering the next generation of healthcare leaders.
Carl`s contact details
******@aquestive.com
******@performdev.com
Colleagues
SVP Business Process & IT
Senior Vice President Business Process and IT
Chief Science Officer
VP, Pricing & Market Access
Senior Vice President and Chief Financial Officer | NASDAQ: AQST | Oral Epinephrine
Chief Executive Officer
Chief Operating Officer
Vice President, Associate General Counsel, Corporate Compliance & Privacy Officer
VP, Regulatory Affairs